MoneyWorks4Me

Guj. Inject (Kerala) - Quaterly Results

14 Aug 2025 Evaluate
The sales slipped to Rs. 24.21 millions for the June 2025 quarter as against Rs. 30.45 millions during the year-ago period.Net profit of the cmpany stood at Rs. 0.72 millions for the quarter ended June 2025 a decline of -40.50% from Rs. 1.21 millions  in the same quarter last year.A decline of 0.97 millions was observed in the OP in the quarter ended June 2025 from 1.64 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 24.21 30.45 -20.49 24.21 30.45 -20.49 190.46 57.88 229.06
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 1.80 0.61 195.08
PBIDT 0.97 1.64 -40.85 0.97 1.64 -40.85 12.55 1.06 1083.96
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00
PBDT 0.97 1.64 -40.85 0.97 1.64 -40.85 12.53 1.06 1082.08
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.97 1.64 -40.85 0.97 1.64 -40.85 12.53 1.06 1082.08
TAX 0.25 0.43 -41.86 0.25 0.43 -41.86 2.37 0.22 977.27
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.72 1.21 -40.50 0.72 1.21 -40.50 10.16 0.84 1109.52
Equity 146.35 146.35 0.00 146.35 146.35 0.00 146.35 112.92 29.61
PBIDTM(%) 4.01 5.39 -25.61 4.01 5.39 -25.61 6.59 1.83 259.80
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..